Channing Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Channing Capital Management's ELV Position: Q2 2026 in Review
Channing Capital Management reduced its Elevance Health (ELV) stake by 22% in Q2 2026, selling an estimated $2.57M and leaving 24,561 shares worth $9.5M. The position accounts for 0.22% of the portfolio, ranked #86.
Channing Capital Management first reported a position in ELV in Q1 2019 and has held it in 17 quarters since. The position peaked at $11.6M in Q3 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Channing Capital Management held 24,561 shares of Elevance Health worth $9.5M as of Q2 2026.
- Channing Capital Management sold 6,932 Elevance Health shares in Q2 2026, an estimated $2.57M.
- Elevance Health made up 0.22% of Channing Capital Management's portfolio in Q2 2026, its #86 holding.
- Channing Capital Management first reported a position in Elevance Health in Q1 2019 and has held it in 17 quarters since.
- Channing Capital Management's Elevance Health position peaked at $11.6M in Q3 2025.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Channing Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.